Richard G. Vincent - Jan 27, 2022 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Financial Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jan 27, 2022
Transactions value $
$21,625
Form type
4
Date filed
1/31/2022, 03:00 PM
Previous filing
Jan 24, 2022
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Purchase $9K +5K +7.08% $1.80 75.7K Jan 27, 2022 Direct
transaction ONCT Common Stock Purchase $8.5K +5K +6.61% $1.70 80.7K Jan 27, 2022 Direct
transaction ONCT Common Stock Purchase $4.13K +2.5K +3.1% $1.65 83.2K Jan 28, 2022 Direct
holding ONCT Common Stock 4.53K Jan 27, 2022 By Family Trust
holding ONCT Common Stock 1.83K Jan 27, 2022 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.